EKF Diagnostics USA products

The HemoPoint® H2 Hemoglobin Meter provides a precise hemoglobin and hematocrit* measurement in as quick as 30 seconds – One test. Two results. The HemoPoint® H2 Hemoglobin Analyzer provides a hemoglobin measurement and a hematocrit calculation* from 30 seconds. HemoPoint H2 Hemoglobin Meter is CLIA waived and enables users to perform tests quickly and easily.

QuStick Strep A Rapid Test’s ultra-sensitivity means that it requires fewer colonies to yield a positive result. Which means that even patients presenting less obvious symptoms can be detected. QuStick Strep A Rapid Test from EKF Diagnostics provides qualitative detection of Group A Streptococcal Antigen directly from patient throat swab specimens within five minutes.QuStick Strep A Rapid Test is highly sensitive and has been proven to detect difficult cases that other rapid streptococcal tests may miss. It requires fewer bacterial colonies to be present in order to provide a positive result.

Hema-Screen is CLIA waived and uses a guaiac methodology that helps minimize the challenges associated with testing fecal specimens. The cost-effective Hema-Screen® Lab Pack is designed to collect and test specimens for signs of Occult Blood – an early sign of colorectal cancer. The assay is performed in the laboratory and utilizes on-slide positive and negative monitors. Results are provided in two minutes. Each test kit comes complete with Hema-Screen developing solution, wooden applicators, simple-to-follow instructions and a technical insert. Hema-Screen lab packs can be stored at room temperature.

The UltraCrit™ Hematocrit Device is a CLIA waived hematocrit device, high accuracy hematocrit measurement for blood donor screening. EKF Diagnostics UltraCrit™Hematocri device is a point-of-care hematocrit device delivering highly accurate measurements for blood donor screening. UltraCrit™Hematocrit Device is a unique technology, developed in the USA. It is the first and only hematocrit/hemoglobin device to use ultrasound methodology. Using the highly accurate ultrasound method means blood banks can be confident that they will minimize the number of false deferrals and false accepts. UltraCrit™Hematocrit Device cuvettes use a 40 μl blood sample which is then inserted into the device. Results are displayed within 30 seconds.